Rallybio's market cap is currently $30.47M. The company's EPS TTM is $-1.589; its P/E ratio is ―; Rallybio is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -150.00K	$ -167.00K	$ -109.00K	$ -62.03K	$ -26.34K
Operating Income	$ -78.93M	$ -67.88M	$ -45.65M	$ -25.30M	$ -17.64M
EBITDA	$ -72.37M	$ -65.41M	$ -45.39M	$ -24.83M	$ -17.39M
Net Income	$ -74.56M	$ -66.49M	$ -47.01M	$ -24.93M	$ -17.63M
Balance Sheet
Cash & Short-Term Investments	$ 109.93M	$ 168.99M	$ 175.33M	$ 140.23M	$ 19.46M
Total Assets	$ 115.62M	$ 180.44M	$ 182.19M	$ 141.86M	$ 21.61M
Total Debt	$ 392.00K	$ 555.00K	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -24.10M	$ -56.40M	$ -175.33M	$ -140.23M	$ -19.46M
Total Liabilities	$ 9.44M	$ 11.12M	$ 6.58M	$ 187.88M	$ 41.89M
Stockholders' Equity	$ 106.18M	$ 169.32M	$ 175.60M	$ -47.01M	$ -20.57M
Cash Flow
Free Cash Flow	$ -60.28M	$ -57.34M	$ -45.87M	$ -22.18M	$ -15.21M
Operating Cash Flow	$ -60.27M	$ -57.28M	$ -45.53M	$ -22.04M	$ -15.03M
Investing Cash Flow	$ 27.66M	$ -112.17M	$ -2.33M	$ -2.07M	$ -188.00K
Financing Cash Flow	$ 143.00K	$ 51.08M	$ 82.97M	$ 144.89M	$ 31.57M

Currency in USD

Rallybio Earnings and Revenue History

Income Statement >

Rallybio Debt to Assets

Balance Sheet >

Rallybio Cash Flow

Cash Flow >

Rallybio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing